Fibroblast growth factor‐21 (FGF21), which is expressed in fat, skeletal muscle, and liver, increases glucose‐induced ISF in rodent islets,33 and the plasma FGF21 increases with the severity of liver fibrosis in NAFLD.34 Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.